DOI QR코드

DOI QR Code

Prognostic Value of Pretreatment Serum Alkaline Phosphatase in Nasopharyngeal Carcinoma

  • Xie, Ying (Guangxi Key Laboratory for High-incidence Tumor Prevention and Treatment, Experimental Center of Medical Science of Guangxi Medical University) ;
  • Wei, Zheng-Bo (Department of Head and Neck Tumor Surgery, Affiliated Tumor Hospital of Guangxi Medical University) ;
  • Duan, Xu-Wei (Department of Head and Neck Tumor Surgery, Affiliated Tumor Hospital of Guangxi Medical University)
  • 발행 : 2014.04.30

초록

Background: The prognostic value of serum alkaline phosphatase (S-ALP) has not been fully validated for nasopharyngeal carcinoma (NPC). Materials and Methods: S-ALP levels were measured in 601 patients newly diagnosed with NPC before radical treatment, and possible associations of these levels with 5-year overall survival (OS) and tumor-free survival (TFS) were explored using univariate and multivariate analyses. Results: Elevated pretreatment S-ALP (>85 U/L) was significantly less frequent among patients classified as T1+2 or stage I+II than among those classified as T3+4 or stage III+IV. Multivariate analysis showed that elevated pretreatment S-ALP (>85 U/L), age, T classification and N stage were independent predictors of poor OS and TFS. Conclusions: Pretreatment S-ALP may be a reliable biomarker to evaluate the long-term prognosis of patients with NPC.

참고문헌

  1. Van Hoof VO, Van Oosterom AT, Lepoutre LG, De Broe ME (1992). Alkaline phosphatase isoenzyme patterns in malignant disease. Clin Chem, 38, 2546-51.
  2. Tang LL, Li WF, Chen L, et al (2010). Prognostic value and staging categories of anatomic masticator space involvement in nasopharyngeal carcinoma: a study of 924 cases with MR imaging. Radiology, 257, 151-7. https://doi.org/10.1148/radiol.10100033
  3. Teo PM, Chan AT (2002). Treatment strategy and clinical experience. Semin Cancer Biol, 12, 497-504. https://doi.org/10.1016/S1044579X02000925
  4. Turan S, Topcu B, Gokce I, et al (2011). Serum alkaline phosphatase levels in healthy children and evaluation of alkaline phosphatase z-scores in different types of rickets. J Clin Res Pediatr Endocrinol, 3, 7-11. https://doi.org/10.4274/jcrpe.v3i1.02
  5. Wan XB, Wei L, Li H, et al (2013). High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma. Eur J Cancer, 49, 2356-64. https://doi.org/10.1016/j.ejca.2013.03.008
  6. Wei JS, Chung NC, Wei LL, et al (1993). High-molecular-mass alkaline phosphatase as a tumor marker for colorectal cancer:comparison of two test methods. Clin Chem, 39, 540-3.
  7. Wei ZB, Zeng XJ, Xu J, et al (2014). Prognostic value of pretreatment serum levels of lactate dehydrogenase in nonmetastatic nasopharyngeal carcinoma: single-site analysis of 601 patients in a highly endemic area. Onco Targets Ther, 7, 739-49
  8. Wildeman MA, Fles R, Adham M, et al (2012). Short-term effect of different teaching methods on nasopharyngeal carcinoma for general practitioners in Jakarta, Indonesia. PLoS One, 7, 32756. https://doi.org/10.1371/journal.pone.0032756
  9. Yu MC, Yuan JM (2002). Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol, 12, 421-9. https://doi.org/10.1016/S1044579X02000858
  10. Ma J, Wen ZS, Lin P, et al (2010). The results and prognosis of different treatment modalities for solitary metastatic lung tumor from nasopharyngeal carcinoma: a retrospective study of 105 cases. Chin J Cancer, 29, 787-95. https://doi.org/10.5732/cjc.010.10098
  11. Limdi JK, Hyde GM (2003). Evaluation of abnormal liver function tests. Postgrad Med J, 79, 307-12. https://doi.org/10.1136/pmj.79.932.307
  12. Lorente JA., Valenzuela H, Morote J, Gelabert A (1999). Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients. Eur J Nucl Med, 26, 625-32. https://doi.org/10.1007/s002590050430
  13. Ma BB, Leungm SF, Hui EP, et al (2004). Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy. Cancer, 101, 776-81. https://doi.org/10.1002/cncr.20430
  14. Mazumdar M, Glassman JR (2000). Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments. Stat Med, 19, 113-32. https://doi.org/10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O
  15. Qin HD, Shugart YY, Bei JX, et al (2011). Comprehensive pathway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma. Cancer Res, 71, 3000-8. https://doi.org/10.1158/0008-5472.CAN-10-0469
  16. Saif MW, Alexander D, Wicox CM (2005). Serum Alkaline Phosphatase Level as a Prognostic Tool in Colorectal Cancer: A Study of 105 patients. J Appl Res, 5, 88-95.
  17. Sonpavde G, Pond G R, Berry WR, et al (2012). Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy. Urol Oncol, 30, 607-13. https://doi.org/10.1016/j.urolonc.2010.07.002
  18. Sripanidkulchai B, Areejitnusorn P, Sriamporn S, et al (2004). Serum gamma-glutamyl transpeptidase and alkaline phosphatase of people in Khon Kaen, the northeastern Thailand. Asian Pac J Cancer Prev, 5, 54-7.
  19. Crivellari D, Price K N, Hagen M, et al (1995). Routine tests during follow-up of patients after primary treatment for operable breast cancer. International (Ludwig) Breast Cancer Study Group (IBCSG). Ann Oncol, 6, 769-76.
  20. Bacci G, Longhi A, Ferrari S, et al (2002). Prognostic significance of serum alkaline phosphatase in osteosarcoma of the extremity treated with neoadjuvant chemotherapy: recent experience at Rizzoli Institute. Oncol Rep, 9, 171-5.
  21. Chen H, Luo YL, Zhang L, et al (2013). EA-D p45-IgG as a potential biomarker for nasopharyngeal carcinoma diagnosis. Asian Pac J Cancer Prev, 14, 7433-8. https://doi.org/10.7314/APJCP.2013.14.12.7433
  22. Cheng SH, Tsai SY, Horng CF, et al (2006). A prognostic scoring system for locoregional control in nasopharyngeal carcinoma following conformal radiotherapy. Int J Radiat Oncol Biol Phys, 66, 992-1003. https://doi.org/10.1016/j.ijrobp.2006.06.006
  23. Fandi A., Bachouchi M, Azli N, et al (2000). Long-term diseasefree survivors in metastatic undifferentiated carcinoma of nasopharyngeal type. J Clin Oncol, 18, 1324-30.
  24. Fei ZH, Yao CY, Yang, XL, et al (2013). Serum BMP-2 upregulation as an indicator of poor survival in advanced non-small cell lung cancer patients. Asian Pac J Cancer Prev, 14, 5293-9. https://doi.org/10.7314/APJCP.2013.14.9.5293
  25. Han J, Yong B, Luo C, et al (2012). High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China. World J Surg Oncol, 10, 37. https://doi.org/10.1186/1477-7819-10-37
  26. Huncharek M, Kupelnick B (2002). Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1, 528 patients from six randomized trials. Am J Clin Oncol, 25, 219-23. https://doi.org/10.1097/00000421-200206000-00002
  27. Li G, Gao J, Tao YL, et al (2012). Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma. Chin J Cancer, 31, 197-206. https://doi.org/10.5732/cjc.011.10283
  28. Aminian A, Karimian F, Mirsharifi R, et al (2011). Correlation of serum alkaline phosphatase with clinicopathological characteristics of patients with oesophageal cancer. East Mediterr Health J, 17, 862-6.
  29. Akimoto S, Furuya Y, Akakura K, Ito H (1998). Comparison of markers of bone formation and resorption in prostate cancer patients to predict bone metastasis. Endocr J, 45, 97-104. https://doi.org/10.1507/endocrj.45.97
  30. Al-Batran S, Wirtz R, Pauligk C, et al (2008). Association of elevated matrix metalloproteinase-9 (MMP-9) mRNA expression levels with resistance to chemotherapy and survival in patients with metastatic gastric cancer receiving first-line chemotherapy: results from the FLO versus FLP gastric cancer phase III trial of the AIO. J Clin Oncol (Meeting Abstract), 4544.
  31. Altman DG, Lausen B, Sauerbrei W, Schumacher M (1994). Dangers of using “optimal” cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst, 86, 829-35. https://doi.org/10.1093/jnci/86.11.829
  32. Au JS, Law CK, Foo W, Lau WH (2003). In-depth evaluation of the AJCC/UICC 1997 staging system of nasopharyngeal carcinoma: prognostic homogeneity and proposed refinements. Int J Radiat Oncol Biol Phys, 56, 413-26. https://doi.org/10.1016/S0360-3016(02)04610-2

피인용 문헌

  1. Prognostic Model Built on Blood-based Biomarkers in Patients with Metastatic Colorectal Cancer vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7327
  2. Value of the prognostic nutritional index and weight loss in predicting metastasis and long-term mortality in nasopharyngeal carcinoma vol.13, pp.1, 2015, https://doi.org/10.1186/s12967-015-0729-0
  3. Model Based on Alkaline Phosphatase and Gamma-Glutamyltransferase for Gallbladder Cancer Prognosis vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6255
  4. RASSF1A Gene Methylation is Associated with Nasopharyngeal Carcinoma Risk in Chinese vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2283
  5. Exploring the diagnosis markers for gallbladder cancer based on clinical data vol.9, pp.3, 2015, https://doi.org/10.1007/s11684-015-0402-2
  6. The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma vol.37, pp.2, 2016, https://doi.org/10.1007/s13277-015-3851-y